LobbyingSarepta Therapeutics lobbying by quarter
Sarepta Therapeutics SRPT's latest lobbying report covers Q2 2026, at $360K. The four quarters Q4 2025–Q3 2026 total $1.3M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Sarepta TherapeuticsSRPT
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.3M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $280K | 3 |
| Q1 2023 | $240K | 2 |
| Q2 2023 | $300K | 2 |
| Q3 2023 | $370K | 2 |
| Q4 2023 | $320K | 2 |
| Q1 2024 | $320K | 2 |
| Q2 2024 | $320K | 2 |
| Q3 2024 | $330K | 2 |
| Q4 2024 | $370K | 2 |
| Q1 2025 | $400K | 2 |
| Q2 2025 | $380K | 3 |
| Q3 2025 | $620K | 3 |
| Q4 2025 | $430K | 3 |
| Q1 2026 | $470K | 3 |
| Q2 2026 | $360K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.1M · 35 reports
- Taxation$1.1M · 12 reports
- Science and technology$895K · 10 reports
- Budget and appropriations$485K · 17 reports
- Medicare and Medicaid$410K · 15 reports
- Pharmacy$260K · 3 reports
- Medical research and clinical labs$210K · 5 reports
- Trade$55K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES36 reports
- SENATE36 reports
- Centers For Medicare and Medicaid Services (CMS)9 reports
- Health & Human Services, Dept of (HHS)6 reports
- Executive Office of the President (EOP)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSarepta Therapeutics | $3.8M | 15 quarters |
| Tarplin, Downs & Young | $1.2M | 15 quarters |
| Michael Best Strategies | $420K | 5 quarters |
| Cornerstone Government Affairs | $20K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner | Q2 2026 |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham | Q2 2026 |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | Q2 2026 |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance | Q2 2026 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q2 2026 |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun | Q2 2026 |
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. | Q2 2026 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q2 2026 |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. | Q2 2026 |
| MADISON SMITH | Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert | Q1 2026 |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee | Q3 2025 |
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance | Q4 2024 |
| KARYN RICHMAN | Program Examiner, Executive Office of the President, Office of Management and Budget; Professional Staff, House Appropriations Committee | Q4 2022 |
| MARK MIODUSKI | Prof Staff; House Approps Cmte (Obey) | Q4 2022 |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Michael Best Strategies | $50K |
| 07/20for Q2 | Tarplin, Downs & Young | $90K |
| 07/20for Q2 | In-house | $220K |
| 04/20for Q1 | Michael Best Strategies | $110K |
| 04/20for Q1 | In-house | $270K |
| 04/20for Q1 | Tarplin, Downs & Young | $90K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $90K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $90K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $90K |
| 01/20for Q4 2025 | Michael Best Strategies | $110K |
| 01/20for Q4 2025 | In-house | $230K |
| 25/10/20for Q3 2025 | Michael Best Strategies | $110K |
| 25/10/20for Q3 2025 | Tarplin, Downs & Young | $80K |
| 25/10/15for Q3 2025 | In-house | $430K |
| 25/07/21for Q2 2025 | Michael Best Strategies | $40K |
| 25/07/21for Q2 2025 | Tarplin, Downs & Young | $80K |
| 25/07/16for Q2 2025 | In-house | $260K |
| 25/07/15for Q2 2025 | Michael Best Strategies | Under $5,000 |
| 25/04/20for Q1 2025 | Tarplin, Downs & Young | $80K |
| 25/04/16for Q1 2025 | In-house | $320K |